Literature DB >> 11323400

Changes in essential fatty acid patterns associated with normal liver regeneration and the progression of hepatocyte nodules in rat hepatocarcinogenesis.

S Abel1, C M Smuts, C de Villiers, W C Gelderblom.   

Abstract

Changes in lipid metabolism were monitored in rat hepatocyte nodules at certain time points over 9 months. Tissue obtained from partially hepatectomized rats, collected over a period of 7 days, were included as a control for normal hepatocyte cell proliferation. Two important features regarding the lipid profiles of hepatocyte nodules and normal regenerating liver were the increased concentrations of phosphatidylethanolamine (PE), resulting in a decreased phosphatidylcholine/phosphatidylethanolamine (PC/PE) ratio, and cholesterol. These changes coincided with increased membrane fluidity in the nodules and regenerating liver. With respect to the fatty acid (FA) profiles of the nodules, C18:1omega9 and C18:2omega6 increased in PE and PC whereas C20:4omega6 decreased in PC and increased in PE. C22:5omega6 and C22:6omega3, the end products of the omega6 and omega3 metabolic pathways, respectively, decreased in PC and remained unchanged in PE. The FA levels in PC reflected an impaired delta-6 desaturase enzyme, whereas this effect was masked in PE due to the increased concentration of this phospholipid fraction. In regenerating liver, the FA profiles of PC and PE showed the same pattern as described for the hepatocyte nodules, except for C18:1omega9 which decreased in PC and increased non-significantly in PE. The increased C18:1omega9 level, a FA with anti-oxidative properties, as well as the decreased levels of the long-chain polyunsaturated fatty acids (C20 and C22 carbon chains), have been associated with the decreased lipid peroxidation level in hepatocyte nodules. The resultant decrease in peroxidative metabolites, known to affect apoptosis, could be important in the progression of the nodules into neoplasia. The present results indicate that the altered lipid parameters associated with hepatocyte nodules closely mimics cellular proliferation in regenerating liver and could be responsible for the enhanced proliferation and/or altered growth pattern in these lesions. The altered FA profiles suggest various pathways in which FA could play a role in transmembrane signalling related to the altered cell proliferative and apoptotic pathways. The persistent changes in the hepatocyte nodules suggest that the lipid metabolism escapes the regulatory mechanisms required for normal cellular homeostasis at different levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11323400     DOI: 10.1093/carcin/22.5.795

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  18 in total

1.  The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy.

Authors:  Yuan Guan; Xinyu Chen; Manhong Wu; Wan Zhu; Ahmed Arslan; Saori Takeda; Mindie H Nguyen; Ravindra Majeti; Dan Thomas; Ming Zheng; Gary Peltz
Journal:  J Hepatol       Date:  2019-11-22       Impact factor: 25.083

2.  Histone Deacetylase SIRT1 Controls Proliferation, Circadian Rhythm, and Lipid Metabolism during Liver Regeneration in Mice.

Authors:  Marina Maria Bellet; Selma Masri; Giuseppe Astarita; Paolo Sassone-Corsi; Maria Agnese Della Fazia; Giuseppe Servillo
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

3.  Non-mammalian fat-1 gene prevents neoplasia when introduced to a mouse hepatocarcinogenesis model: Omega-3 fatty acids prevent liver neoplasia.

Authors:  J Griffitts; D Saunders; Y A Tesiram; G E Reid; A Salih; S Liu; T A Lydic; J V Busik; J X Kang; R A Towner
Journal:  Biochim Biophys Acta       Date:  2010-07-08

4.  Influence of phospholipid species on membrane fluidity: a meta-analysis for a novel phospholipid fluidity index.

Authors:  Val Andrew Fajardo; Lauren McMeekin; Paul J LeBlanc
Journal:  J Membr Biol       Date:  2011-11-04       Impact factor: 1.843

5.  Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis.

Authors:  Yexiong Tan; Peiyuan Yin; Liang Tang; Wenbin Xing; Qiang Huang; Dan Cao; Xinjie Zhao; Wenzhao Wang; Xin Lu; Zhiliang Xu; Hongyang Wang; Guowang Xu
Journal:  Mol Cell Proteomics       Date:  2011-11-14       Impact factor: 5.911

6.  Lipids and delta6-desaturase activity alterations in rat liver microsomal membranes induced by fumonisin B1.

Authors:  W C A Gelderblom; W Moritz; S Swanevelder; C M Smuts; S Abel
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

7.  Transport and metabolism of radiolabeled choline in hepatocellular carcinoma.

Authors:  Yu Kuang; Nicolas Salem; David J Corn; Bernadette Erokwu; Haibin Tian; Fangjing Wang; Zhenghong Lee
Journal:  Mol Pharm       Date:  2010-09-21       Impact factor: 4.939

8.  Differential genome-wide gene expression profiling of bovine largest and second-largest follicles: identification of genes associated with growth of dominant follicles.

Authors:  Ken-Go Hayashi; Koichi Ushizawa; Misa Hosoe; Toru Takahashi
Journal:  Reprod Biol Endocrinol       Date:  2010-02-05       Impact factor: 5.211

9.  Altered lipid parameters in hepatic subcellular membrane fractions induced by fumonisin B1.

Authors:  H-M Burger; S Abel; P W Snijman; S Swanevelder; W C A Gelderblom
Journal:  Lipids       Date:  2007-02-09       Impact factor: 1.880

10.  In vivo MRS assessment of altered fatty acyl unsaturation in liver tumor formation of a TGF alpha/c-myc transgenic mouse model.

Authors:  J Griffitts; Y Tesiram; G E Reid; D Saunders; R A Floyd; R A Towner
Journal:  J Lipid Res       Date:  2008-12-08       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.